Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,576 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The efficacy of shortening the dosing interval to once every six weeks in Crohn's patients losing response to maintenance dose of infliximab.
Kopylov U, Mantzaris GJ, Katsanos KH, Reenaers C, Ellul P, Rahier JF, Israeli E, Lakatos PL, Fiorino G, Cesarini M, Tsianos EV, Louis E, Ben-Horin S. Kopylov U, et al. Among authors: louis e. Aliment Pharmacol Ther. 2011 Feb;33(3):349-57. doi: 10.1111/j.1365-2036.2010.04523.x. Epub 2010 Dec 1. Aliment Pharmacol Ther. 2011. PMID: 21118397 Free article.
Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease.
Franchimont N, Putzeys V, Collette J, Vermeire S, Rutgeerts P, De Vos M, Van Gossum A, Franchimont D, Fiasse R, Pelckmans P, Malaise M, Belaiche J, Louis E. Franchimont N, et al. Among authors: louis e. Aliment Pharmacol Ther. 2004 Sep 15;20(6):607-14. doi: 10.1111/j.1365-2036.2004.02152.x. Aliment Pharmacol Ther. 2004. PMID: 15352908 Free article. Clinical Trial.
Infliximab and the bone in Crohn's disease.
Franchimont N, Reenaers C, Louis E. Franchimont N, et al. Among authors: louis e. Aliment Pharmacol Ther. 2005 Apr 1;21(7):918-9. doi: 10.1111/j.1365-2036.2005.02434.x. Aliment Pharmacol Ther. 2005. PMID: 15801928 Free article. No abstract available.
The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies.
Allez M, Vermeire S, Mozziconacci N, Michetti P, Laharie D, Louis E, Bigard MA, Hébuterne X, Treton X, Kohn A, Marteau P, Cortot A, Nichita C, van Assche G, Rutgeerts P, Lémann M, Colombel JF. Allez M, et al. Among authors: louis e. Aliment Pharmacol Ther. 2010 Jan;31(1):92-101. doi: 10.1111/j.1365-2036.2009.04130.x. Aliment Pharmacol Ther. 2010. PMID: 19709098 Free article.
1,576 results